Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 68
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Anticancer Drugs ; 33(1): e21-e27, 2022 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-34561998

RESUMO

The nucleolus is the site of ribosome biogenesis and is found to play an important role in stress sensing. For over 100 years, the increase in the size and number of nucleoli has been considered as a marker of aggressive tumors. Despite this, the contribution of the nucleolus and the biologic processes mediated by it to cancer pathogenesis has been largely overlooked. This state has been changed over the recent decades with the demonstration that the nucleolus controls numerous cellular functions associated with cancer development. Induction of nucleolar stress has recently been regarded as being superior to conventional cytotoxic/cytostatic strategy in that it is more selective to neoplastic cells while sparing normal cells. Natural products represent an excellent source of bioactive molecules and some of them have been found to be able to induce nucleolar stress. The demonstration of these nucleolar stress-inducing natural products has paved the way for a new therapeutic approach to more delicate tumor cell-killing. This review provides a contemporary summary of the role of the nucleolus as a novel promising target for cancer therapy, with particular emphasis on natural products as an exciting new class of anti-cancer drugs with nucleolar stress-inducing properties.


Assuntos
Antineoplásicos/farmacologia , Produtos Biológicos/farmacologia , Nucléolo Celular/efeitos dos fármacos , Neoplasias/patologia , DNA Ribossômico/efeitos dos fármacos , Humanos , Neoplasias/tratamento farmacológico , RNA Polimerase I/efeitos dos fármacos , RNA Ribossômico/efeitos dos fármacos , Estresse Fisiológico/efeitos dos fármacos
2.
Sex Transm Dis ; 43(9): 579-83, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27513385

RESUMO

BACKGROUND: High rates of 23S rDNA mutations implicated in macrolide resistance have been identified in Treponema pallidum samples from syphilis patients in many countries. Nonetheless, some clinicians have been reluctant to abandon azithromycin as a treatment for syphilis, citing the lack of a causal association between these mutations and clinical evidence of drug resistance. Although azithromycin resistance has been demonstrated in vivo for the historical Street 14 strain, no recent T. pallidum isolates have been tested. We used the well-established rabbit model of syphilis to determine the in vivo efficacy of azithromycin against 23S rDNA mutant strains collected in 2004 to 2005 from patients with syphilis in Seattle, Wash. METHODS: Groups of 9 rabbits were each infected with a strain containing 23S rDNA mutation A2058G (strains UW074B, UW189B, UW391B) or A2059G (strains UW228B, UW254B, and UW330B), or with 1 wild type strain (Chicago, Bal 3, and Mexico A). After documentation of infection, 3 animals per strain were treated with azithromycin, 3 were treated with benzathine penicillin G, and 3 served as untreated control groups. Treatment efficacy was documented by darkfield microscopic evidence of T. pallidum, serological response, and rabbit infectivity test. RESULTS: Azithromycin uniformly failed to cure rabbits infected with strains harboring either 23S rDNA mutation, although benzathine penicillin G was effective. Infections caused by wild type strains were successfully treated by either azithromycin or benzathine penicillin G. CONCLUSIONS: A macrolide resistant phenotype was demonstrated for all strains harboring a 23S rDNA mutation, demonstrating that either A2058G or A2059G mutation confers in vivo drug resistance.


Assuntos
DNA Bacteriano/efeitos dos fármacos , DNA Ribossômico/efeitos dos fármacos , Farmacorresistência Bacteriana/genética , Macrolídeos/farmacologia , Treponema pallidum/genética , Animais , Antibacterianos/farmacologia , Azitromicina/farmacologia , Modelos Animais de Doenças , Humanos , Mutação/efeitos dos fármacos , Penicilina G Benzatina/farmacologia , Coelhos , Sífilis/tratamento farmacológico , Treponema pallidum/isolamento & purificação
3.
G3 (Bethesda) ; 6(9): 2829-38, 2016 09 08.
Artigo em Inglês | MEDLINE | ID: mdl-27449518

RESUMO

The Saccharomyces cerevisiae ribosomal DNA (rDNA) locus is known to exhibit greater instability relative to the rest of the genome. However, wild-type cells preferentially maintain a stable number of rDNA copies, suggesting underlying genetic control of the size of this locus. We performed a screen of a subset of the Yeast Knock-Out (YKO) single gene deletion collection to identify genetic regulators of this locus and to determine if rDNA copy number correlates with yeast replicative lifespan. While we found no correlation between replicative lifespan and rDNA size, we identified 64 candidate strains with significant rDNA copy number differences. However, in the process of validating candidate rDNA variants, we observed that independent isolates of our de novo gene deletion strains had unsolicited but significant changes in rDNA copy number. Moreover, we were not able to recapitulate rDNA phenotypes from the YKO yeast deletion collection. Instead, we found that the standard lithium acetate transformation protocol is a significant source of rDNA copy number variation, with lithium acetate exposure being the treatment causing variable rDNA copy number events after transformation. As the effects of variable rDNA copy number are being increasingly reported, our finding that rDNA is affected by lithium acetate exposure suggested that rDNA copy number variants may be influential passenger mutations in standard strain construction in S. cerevisiae.


Assuntos
Variações do Número de Cópias de DNA/genética , Replicação do DNA/genética , DNA Ribossômico/genética , Saccharomyces cerevisiae/genética , Acetatos/toxicidade , Replicação do DNA/efeitos dos fármacos , DNA Ribossômico/efeitos dos fármacos , Deleção de Genes , Técnicas de Inativação de Genes , Genoma Fúngico , Fenótipo , Ribossomos/efeitos dos fármacos , Ribossomos/genética , Saccharomyces cerevisiae/efeitos dos fármacos
4.
Folia Biol (Praha) ; 61(2): 49-59, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26333121

RESUMO

We studied the effect of ellagic acid (EA) on the morphology of nucleoli and on the pattern of major proteins of the nucleolus. After EA treatment of HeLa cells, we observed condensation of nucleoli as documented by the pattern of argyrophilic nucleolar organizer regions (AgNORs). EA also induced condensation of RPA194-positive nucleolar regions, but no morphological changes were observed in nucleolar compartments positive for UBF1/2 proteins or fibrillarin. Studied morphological changes induced by EA were compared with the morphology of control, non-treated cells and with pronounced condensation of all nucleolar domains caused by actinomycin D (ACT-D) treatment. Similarly as ACT-D, but in a lesser extent, EA induced an increased number of 53BP1-positive DNA lesions. However, the main marker of DNA lesions, γH2AX, was not accumulated in body-like nuclear structures. An increased level of γH2AX was found by immunofluorescence and Western blots only after EA treatment. Intriguingly, the levels of fibrillarin, UBF1/2 and γH2AX were increased at the promoters of ribosomal genes, while 53BP1 and CARM1 levels were decreased by EA treatment at these genomic regions. In the entire genome, EA reduced H3R17 dimethylation. Taken together, ellagic acid is capable of significantly changing the nucleolar morphology and protein levels inside the nucleolus.


Assuntos
Proteínas Adaptadoras de Sinalização CARD/antagonistas & inibidores , Nucléolo Celular/efeitos dos fármacos , DNA Ribossômico/efeitos dos fármacos , Ácido Elágico/farmacologia , Epigênese Genética/efeitos dos fármacos , Guanilato Ciclase/antagonistas & inibidores , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Proteínas Adaptadoras de Sinalização CARD/análise , Divisão Celular/efeitos dos fármacos , Nucléolo Celular/química , Nucléolo Celular/ultraestrutura , Proteínas Cromossômicas não Histona/análise , Dano ao DNA , DNA Ribossômico/genética , Dactinomicina/farmacologia , Fase G2/efeitos dos fármacos , Guanilato Ciclase/análise , Células HeLa/química , Células HeLa/efeitos dos fármacos , Histonas/análise , Histonas/metabolismo , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/análise , Metilação , Proteínas de Neoplasias/análise , Região Organizadora do Nucléolo/química , Região Organizadora do Nucléolo/efeitos dos fármacos , Região Organizadora do Nucléolo/ultraestrutura , Proteínas Pol1 do Complexo de Iniciação de Transcrição/análise , Regiões Promotoras Genéticas , RNA Polimerase I/análise , Proteína 1 de Ligação à Proteína Supressora de Tumor p53
5.
PLoS One ; 9(12): e114161, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25479606

RESUMO

Sperm chromatin in mammals is packaged in different blocks associated to protamines (PDNA), histones (HDNA), or nuclear matrix proteins. Differential packaging has been related to early or late transcription and also to differential susceptibility to genotoxic damage. Genes located in the more accessible HDNA could be more susceptible to injuries than those located in PDNA, being potential biomarkers of paternal DNA damage. Fish sperm chromatin organization is much diversified, some species lacking protamines and some others totally depleted of histones. Analyzing genotoxic damage in a species homogeneously compacted with some sperm nuclear basic protein type, could help in deciphering the clues of differential susceptibility to damage. In the present study we analyzed in rainbow trout the differential susceptibility of nine genes to UV irradiation and H2O2 treatment. The absence of histones in the sperm nuclei was confirmed by Western blot. The chromatin fractionation in sensitive and resistant regions to PvuII (presumably HDNA-like and PDNA-like, respectively) revealed that the nine genes locate in the same resistant region. The number of lesions promoted was quantified using a qPCR approach. Location of 8-hydroxyguanosine (8-OHdG) was analyzed by immunocytochemistry and confocal microscopy. UV irradiation promoted similar number of lesions in all the analyzed genes and a homogenous distribution of 8-OHdG within the nuclei. 8-OHdG was located in the peripheral area of the nucleus after H2O2 treatment, which promoted a significantly higher number of lesions in developmental-related genes (8.76-10.95 lesions/10 kb) than in rDNA genes (1.05-1.67 lesions/10 kb). We showed for the first time, that differential susceptibility to damage is dependent on the genotoxic mechanism and relies on positional differences between genes. Sensitive genes were also analyzed in cryopreserved sperm showing a lower number of lesions than the previous treatments and a predominant peripheral distribution of oxidative damage (8-OHdG).


Assuntos
Cromatina/efeitos dos fármacos , Cromatina/efeitos da radiação , Dano ao DNA/efeitos dos fármacos , Dano ao DNA/efeitos da radiação , Histonas/genética , Animais , Cromatina/genética , DNA Ribossômico/efeitos dos fármacos , DNA Ribossômico/efeitos da radiação , Peróxido de Hidrogênio/farmacologia , Masculino , Proteínas Nucleares/biossíntese , Proteínas Nucleares/genética , Nucleossomos/efeitos dos fármacos , Nucleossomos/efeitos da radiação , Espermatozoides/efeitos dos fármacos , Espermatozoides/efeitos da radiação , Truta , Raios Ultravioleta
6.
FEMS Yeast Res ; 12(8): 949-57, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22909099

RESUMO

In the ribosomal DNA (rDNA) array of Saccharomyces cerevisiae, DNA replication is arrested by the Fob1 protein in a site-specific manner that stimulates homologous recombination. The silent information regulator Sir2, which is loaded at the replication arrest sites by Fob1, suppresses this recombination event. A plasmid containing Fob1-binding sites, when propagated in a yeast strain lacking SIR2 is integrated into the yeast chromosome in a FOB1-dependent manner. We show that addition of nicotinamide (NAM) to the culture medium can stimulate such plasmid integration in the presence of SIR2. Pulsed-field gel electrophoresis analysis showed that plasmid integration occurred into chromosome XII. NAM-induced plasmid integration was dependent on FOB1 and on the homologous recombination gene RAD52. As NAM inhibits several sirtuins, we examined plasmid integration in yeast strains containing deletions of various sirtuin genes and observed that plasmid integration occurred only in the absence of SIR2, but not in the absence of other histone deacetylases. In the absence of PNC1 that metabolizes NAM, a reduced concentration of NAM was required to induce plasmid integration in comparison with that required in wild-type cells. This study suggests that NAD metabolism and intracellular NAM concentrations are important in Fob1-mediated rDNA recombination.


Assuntos
Cromossomos Fúngicos/genética , Proteínas de Ligação a DNA/genética , Niacinamida/farmacologia , Proteínas de Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/genética , Replicação do DNA/efeitos dos fármacos , DNA Fúngico/efeitos dos fármacos , DNA Ribossômico/efeitos dos fármacos , Proteínas de Ligação a DNA/metabolismo , Eletroforese em Gel de Campo Pulsado , Inativação Gênica/efeitos dos fármacos , Plasmídeos/genética , Recombinação Genética/efeitos dos fármacos , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Proteínas Reguladoras de Informação Silenciosa de Saccharomyces cerevisiae/genética , Proteínas Reguladoras de Informação Silenciosa de Saccharomyces cerevisiae/metabolismo , Sirtuína 2/genética , Sirtuína 2/metabolismo
7.
Biol Pharm Bull ; 34(5): 779-82, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21532173

RESUMO

Stems of genus Dendrobium (Orchidaceae) have been traditionally used as an herbal medicine (Dendrobii Herba) in Eastern Asia. Although demand for Dendrobium is increasing rapidly, wild resources are decreasing due to over-collection. This study aimed to identify plant sources of Dendrobii Herba on the market based on sequences of the internal transcribed spacer (ITS) regions of nuclear ribosomal DNA. We constructed an ITS1-5.8S-ITS2 sequence database of 196 Dendrobium species, and the database was employed to identify 21 herbal samples. We found that 13 Dendrobium species (D. catenatum, D. cucullatum, D. denudans, D. devonianum, D. eriiflorum, D. hancockii, D. linawianum, D. lituiflorum, D. loddigesii, D. polyanthum, D. primulinum, D. regium, and D. transparens) were possibly used as plant sources of Dendrobii Herba, and unidentified species allied to D. denudans, D. eriiflorum, D. gregulus, or D. hemimelanoglossum were also used as sources. Furthermore, it is clear that D. catenatum is one of the most important sources of Dendrobii Herba (5 out of 21 samples).


Assuntos
DNA Ribossômico/efeitos dos fármacos , Dendrobium/química , Medicina Herbária , Sequência de Bases , Primers do DNA , Reação em Cadeia da Polimerase
8.
Drug Discov Today ; 15(1-2): 33-9, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19883791

RESUMO

Ribosomal RNA (rRNA)-targeting drugs inhibit protein synthesis and represent effective antibiotics for the treatment of infectious diseases. Given the bacterial origins of mitochondria, the molecular and structural components of the protein expression system are much alike. Moreover, the mutational rate of mitochondrial rRNAs is higher than that of nuclear rRNAs, and some of these mutations might simulate the microorganism's rRNA structure. Consequently, individuals become more susceptible to antibiotics, the mitochondrial function is affected and toxic effects appear. Systems are available to analyze the interaction between antibiotics and mitochondrial DNA genetic variants, thus making a pharmacogenomic approach to antibiotic therapy possible.


Assuntos
Antibacterianos/farmacologia , DNA Mitocondrial/efeitos dos fármacos , RNA/efeitos dos fármacos , Antibacterianos/efeitos adversos , Linhagem Celular Transformada , DNA Ribossômico/efeitos dos fármacos , Variação Genética , Humanos , Mitocôndrias/efeitos dos fármacos , Modelos Genéticos , Fosforilação Oxidativa , Fenótipo , Biossíntese de Proteínas/efeitos dos fármacos , RNA Mitocondrial , RNA Ribossômico/efeitos dos fármacos
9.
Rev Med Chil ; 137(10): 1309-14, 2009 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-20011937

RESUMO

BACKGROUND: Helicobacter pylori antimicrobial resistance rates differ among countries and even between different areas of a country. In Colombia, the most commonly used antimicrobials for the treatment of H pylori infection are amoxicillin, clarithromycin and metronidazole. AIM: To determine antimicrobial susceptibility of H pylori strains isolated in Colombia. MATERIALS AND METHODS: Eighty eight strains of H pylori were isolated and identified by microbiological methods and confirmed with polymerase chain reaction (PCR). The detection of antimicrobial resistance to amoxicillin, clarithromycin, metronidazole and tetraclycline, was conducted by the Etest method. Mutations in the 23S rDNA, involved in resistance to clarithromycin, were detected using PCR and restriction fragment length polymorphism. RESULTS: Eighty eight and 2.2% of the strains were resistant to metronidazole and clarithromycin, respectively. No isolate was simultaneously resistant to amoxicillin or tetracycline. The two clarithromycin resistant strains were homozygous for the A2143G mutation. No mutations were found in the remaining 86 susceptible strains. CONCLUSIONS: The high rate of metronidazole resistance in our population precludes the use of this drug for the empirical treatment of H pylori infection.


Assuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana/genética , Infecções por Helicobacter/microbiologia , Helicobacter pylori/efeitos dos fármacos , Metronidazol/farmacologia , Antibacterianos/classificação , Colômbia/epidemiologia , DNA Ribossômico/efeitos dos fármacos , DNA Ribossômico/genética , Farmacorresistência Bacteriana/efeitos dos fármacos , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/epidemiologia , Helicobacter pylori/genética , Humanos , Testes de Sensibilidade Microbiana/métodos , Mutação/efeitos dos fármacos , Mutação/genética
10.
Rev. méd. Chile ; 137(10): 1309-1314, oct. 2009. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-534037

RESUMO

Background: Helicobacter pylori antimicrobial resistance rates differ among countries and even between different areas of a country. In Colombia, the most commonly used antimicrobials for the treatment of H pylori infection are amoxicillin, clarithromycin and metronidazole. Aim: To determine antimicrobial susceptibility of H pylori strains isolated in Colombia. Materials and methods: Eighty eight strains of H pylori were isolated and identified by microbiological methods and confirmed with polymerase chain reaction (PCR). The detection of antimicrobial resistance to amoxicillin, clarithromycin, metronidazole and tetraclycline, was conducted by the Etest method. Mutations in the 23S rDNA, involved in resistance to clarithromycin, were detected using PCR and restriction fragment lenght polymorphism. Results: Eighty eight and 2.2 percent of the strains were resistant to metronidazole and clarithromycin, respectively. No isolate was simultaneously resistant to amoxicillin or tetracycline. The two clarithromycin resistant strains were homozygous for the A2143G mutation. No mutations were found in the remaining 86 susceptible strains. Conclusions: The high rate of metronidazole resistance in our population precludes the use of this drug for the empirical treatment of Hpylori infection.


Assuntos
Humanos , Antibacterianos/farmacologia , Farmacorresistência Bacteriana/genética , Infecções por Helicobacter/microbiologia , Helicobacter pylori/efeitos dos fármacos , Metronidazol/farmacologia , Antibacterianos/classificação , Colômbia/epidemiologia , DNA Ribossômico/efeitos dos fármacos , DNA Ribossômico/genética , Farmacorresistência Bacteriana/efeitos dos fármacos , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/epidemiologia , Helicobacter pylori/genética , Testes de Sensibilidade Microbiana/métodos , Mutação/efeitos dos fármacos , Mutação/genética
11.
Anticancer Drugs ; 18(7): 763-72, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17581298

RESUMO

We have examined the ability of actinomycin D to induce apoptosis in human peripheral blood lymphocytes. Run-On assays were performed to specify the primary molecular damage, reverse transcription-PCR, Western blots and flow cytometry studies were performed to ascertain which proteins of the apoptosis machinery were affected to cause actinomycin D-induced cell death. Expression of 23 apoptosis-related genes was investigated. The down-regulation of ribosomal RNA synthesis caused by actinomycin D induced a mitochondria-dependent apoptosis. Although the expression of the majority of examined genes remained indifferent against actinomycin D activity, the cellular level of p53 protein increased, subsequently upregulating both Puma mRNA and protein. Puma-mediated mitochondrial apoptosis was accompanied by nucleolin cleavage and Bcl-2 mRNA destabilization. The stability of the cellular level of Bcl-2 protein independent of a mRNA decrease suggests that protection of Bcl-2 protein against proteasomal degradation can moderate the apoptotic process. In peripheral blood lymphocytes cultured in vitro, the apoptosis induced by a low concentration of actinomycin D (10 nmol/l) is dependent on p53 and Puma activation. This apoptotic pathway is demonstrated in peripheral blood lymphocytes for the first time. A different apoptotic pathway induced in peripheral blood lymphocytes using this drug has, however, been previously revealed by other authors. The combination of cell specificity and dose-dependent effects can likely play a decisive role in apoptosis observed in peripheral blood lymphocytes after genotoxic drug application.


Assuntos
Antibióticos Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Dactinomicina/farmacologia , Antibióticos Antineoplásicos/administração & dosagem , Proteínas Reguladoras de Apoptose/metabolismo , Western Blotting , Sobrevivência Celular , Dano ao DNA/efeitos dos fármacos , DNA Ribossômico/efeitos dos fármacos , Dactinomicina/administração & dosagem , Relação Dose-Resposta a Droga , Regulação para Baixo , Citometria de Fluxo , Humanos , Linfócitos/efeitos dos fármacos , Mitocôndrias/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Proteína Supressora de Tumor p53/metabolismo , Regulação para Cima/efeitos dos fármacos
12.
Toxicon ; 50(2): 292-301, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17517427

RESUMO

In November 2005, at least five dogs died rapidly after contact with water from the Hutt River (lower North Island, New Zealand). Necropsy performed 24h later on one of the dogs (a 20-month-old Labrador) revealed few findings of interest, except for copious amounts of froth in the respiratory tract down to the bifurcation of the trachea and large quantities of algal material in the dog's stomach. Low and relatively stable flows in the Hutt River during spring had resulted in the proliferation of benthic cyanobacteria that formed large black/brown mats along the river edge. Samples from the Labrador's stomach contents and cyanobacterial mats were analysed microscopically and screened using chemical and biochemical assays for cyanotoxins: anatoxin-a, homoanatoxin-a, cylindrospermopsins, saxitoxins and microcystins. Liquid chromatography-mass spectrometry (LC-MS) confirmed the presence of the neurotoxic cyanotoxins anatoxin-a and homoanatoxin-a and their degradation products, dihydro-anatoxin-a and dihydro-homoanatoxin-a. This is the first report of homoanatoxin-a and associated degradation product in New Zealand. Based on morphology, the causative species was identified as Phormidium sp. Subsequent phylogenetic analysis of 16S rRNA gene sequences demonstrated that the causative organism was most similar to Phormidium autumnale. Further investigations led to the detection of homoanatoxin-a and anatoxin-a in cyanobacterial mats from four other rivers in the Wellington region (lower North Island, New Zealand). Access restrictions were placed on over 60% of river catchments in the western Wellington region, severely affecting recreational users.


Assuntos
Toxinas Bacterianas/intoxicação , Doenças do Cão/induzido quimicamente , Toxinas Marinhas/intoxicação , Síndromes Neurotóxicas/patologia , Síndromes Neurotóxicas/veterinária , Animais , Compostos Bicíclicos Heterocíclicos com Pontes , Clonagem Molecular , Cianobactérias/química , Cianobactérias/ultraestrutura , DNA Bacteriano/química , DNA Bacteriano/genética , DNA Ribossômico/química , DNA Ribossômico/efeitos dos fármacos , Cães , Conteúdo Gastrointestinal/química , Microcistinas/química , Microcistinas/isolamento & purificação , Microcistinas/toxicidade , Nova Zelândia , RNA Ribossômico 16S/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Saxitoxina/química , Saxitoxina/isolamento & purificação , Saxitoxina/toxicidade , Fixação de Tecidos , Toxoides/química , Toxoides/isolamento & purificação
14.
EMBO J ; 26(2): 448-58, 2007 Jan 24.
Artigo em Inglês | MEDLINE | ID: mdl-17203076

RESUMO

Nutrient starvation or rapamycin treatment, through inhibition of target of rapamycin, causes condensation of ribosomal DNA (rDNA) array and nucleolar contraction in budding yeast. Here we report that under such conditions, condensin is rapidly relocated into the nucleolus and loaded to rDNA tandem repeats, which is required for rDNA condensation. Rpd3-dependent histone deacetylation is necessary and sufficient for condensin's relocalization and loading to rDNA array, suggesting that histone modification plays a regulatory role for condensin targeting. Rapamycin independently, yet coordinately, inhibits rDNA transcription and promotes condensin loading to rDNA array. Unexpectedly, we found that inhibition of rDNA transcription in the absence of condensin loading leads to rDNA instability. Our data suggest that enrichment of condensin prevents rDNA instability during nutrient starvation. Together, these observations unravel a novel role for condensin in the maintenance of regional genomic stability.


Assuntos
Adenosina Trifosfatases/metabolismo , DNA Ribossômico , Proteínas de Ligação a DNA/metabolismo , Alimentos , Instabilidade Genômica , Complexos Multiproteicos/metabolismo , Adenosina Trifosfatases/fisiologia , Antifúngicos/farmacologia , Nucléolo Celular/efeitos dos fármacos , Nucléolo Celular/metabolismo , Segregação de Cromossomos , Cromossomos Fúngicos/metabolismo , Empacotamento do DNA , DNA Ribossômico/efeitos dos fármacos , DNA Ribossômico/metabolismo , Proteínas de Ligação a DNA/fisiologia , Histona Desacetilases/fisiologia , Complexos Multiproteicos/fisiologia , Organismos Geneticamente Modificados , Saccharomycetales , Sirolimo/farmacologia , Transcrição Gênica/efeitos dos fármacos
15.
J Antimicrob Chemother ; 56(3): 491-7, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16055509

RESUMO

BACKGROUND: Erythromycin is the drug of choice to treat human campylobacteriosis. Campylobacter isolates exhibit two different phenotypes with regard to erythromycin resistance: high-level resistant strains (HLR) and low-level resistant strains (LLR). OBJECTIVES: To study the mechanisms of resistance of Campylobacter to erythromycin, its 6-O-methyl derivative clarithromycin and the ketolide telithromycin. RESULTS: We observed a cross-resistance against these three molecules but in contrast, no cross-resistance to quinolones. Analyses of LLR showed no mutation on the 23S rDNA and the presence of a drug transport system, which can be inhibited by phenylalanine arginine beta-naphthylamide (PAbetaN), an efflux-pump inhibitor. In contrast, no PAbetaN-sensitive drug transport was identified in HLR but we found mutations in the rDNA, which were responsible for decreased binding of telithromycin to purified ribosomes. We further showed that the CmeB efflux pump already described in Campylobacter is not involved in the PAbetaN-sensitive transport of telithromycin. CONCLUSIONS: Mutations in the ribosome confer high-level macrolide/ketolide resistance. Low-level resistance was mediated by an efflux mechanism which is sensitive to PAbetaN. This efflux pump was selective to macrolides/ketolide and was different from the previously described Campylobacter efflux pump.


Assuntos
Antibacterianos/farmacologia , Campylobacter/efeitos dos fármacos , Farmacorresistência Bacteriana Múltipla/fisiologia , Macrolídeos/farmacologia , Mutação , Campylobacter/genética , Campylobacter/fisiologia , Claritromicina/farmacologia , DNA Ribossômico/efeitos dos fármacos , DNA Ribossômico/genética , Dipeptídeos/farmacologia , Farmacorresistência Bacteriana Múltipla/genética , Eritromicina/farmacologia , Cetolídeos/farmacologia , Proteínas de Membrana Transportadoras/efeitos dos fármacos , Proteínas de Membrana Transportadoras/genética , Testes de Sensibilidade Microbiana
16.
Eur J Cancer Prev ; 13(4): 239-48, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15554550

RESUMO

The effect of dietary fat on breast cancer is a longstanding and an unresolved issue. We found that 17beta-estradiol (E2) could be activated by the epoxide-forming oxidant dimethyldioxirane (DMDO) to bind DNA-forming DNA adducts both in vitro and in vivo, and to inhibit nuclear RNA synthesis. We proposed that E2 epoxidation is the underlying mechanism for the initiation of breast cancer carcinogenesis (Carcinogenesis 17, 1957-61, 1996). This report is on the transcriptional and DNA-binding properties of vegetable oils and fatty acids, and on the potentials of these compounds to prevent the formation of E2 epoxide. The results show that vegetable oils, having no effect on nuclear RNA synthesis either before or after DMDO treatment, were all able to prevent the formation of E2 epoxide independent of their mono- or polyunsaturated fatty acid content. Similarly, unsaturated fatty acids, regardless of chain length and number of double bonds, were all able to prevent the formation of E2 epoxide as reflected by the loss of the ability of [3H]E2 to bind DNA. In contrast to vegetable oils, the results indicated that the unsaturated fatty acids palmitoleic, oleic, linoleic, linolenic and arachidonic acid could be activated by DMDO to inhibit nuclear RNA synthesis, and that the mono-unsaturated fatty acids (i.e. palmitoleic and oleic acid) were stronger inhibitors than fatty acids with more than one double bond (e.g. linoleic, linolenic and arachidonic acid). [32P]Post-labeling analysis revealed that under identical DMDO activation, the DNA adducts formed for oleic acid were 17098 adducts/10(8) nucleotides, which was 20-fold more than palmitoleic acid (815), and 120-fold more than alpha-linolenic acid (142). This result strongly suggests that oleic acid could be a potential initiating carcinogen after epoxidation.


Assuntos
Anticarcinógenos/farmacologia , Neoplasias da Mama/prevenção & controle , Adutos de DNA/metabolismo , Ácidos Graxos Insaturados/farmacologia , Óleos de Plantas/farmacologia , Animais , Quimioprevenção/métodos , Adutos de DNA/efeitos dos fármacos , DNA Ribossômico/efeitos dos fármacos , DNA Ribossômico/metabolismo , Gorduras na Dieta/farmacologia , Estradiol/farmacologia , Feminino , Humanos , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/metabolismo , Ratos , Sensibilidade e Especificidade , Células Tumorais Cultivadas
17.
Toxicon ; 44(4): 371-83, 2004 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-15302521

RESUMO

The main results of the research performed in the last 30 years on ribosome-inactivating proteins (RIPs) are reviewed, with emphasis on the new, controversial and uncertain aspects. The nature, distribution, mechanism of action and properties of these proteins are briefly reported, together with their possible applications. A pattern appears of a still largely unexplored subject, whose role in nature is probably important, and not limited to the biology of plants, since RIPs have been found also in other organisms.


Assuntos
Imunotoxinas/toxicidade , Inibidores da Síntese de Proteínas/toxicidade , Ribossomos/efeitos dos fármacos , Ricina/toxicidade , Toxinas Biológicas/toxicidade , Antibacterianos/toxicidade , Antivirais/toxicidade , Substâncias para a Guerra Química/toxicidade , DNA Ribossômico/efeitos dos fármacos , Tolerância Imunológica/efeitos dos fármacos , Inseticidas/toxicidade , Proteínas de Plantas/toxicidade , Inibidores da Síntese de Proteínas/metabolismo , Toxinas Biológicas/metabolismo
18.
Cytogenet Genome Res ; 104(1-4): 289-94, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15162053

RESUMO

A human diploid lung fibroblast cell strain, TIG-7, has a heteromorphic chromosome 15 with an extra short arm carrying a homogeneously staining region (15p+hsr). We demonstrated previously that the 15p+hsr consists of an inactive and G+C-rich rDNA cluster characterized by fluorescence in situ hybridization (FISH) and various chromosome banding techniques. Thus, it was suggested that the region could contain highly methylated DNA. To observe methylation status on the target region directly under the microscope, we used a demethylating agent, 5-azacytidine (5-azaC), to induce decondensation of the chromatin containing methylated DNA. At 24 h after treatment with 0.5 microM 5-azaC, marked decondensation of the 15p+hsr was observed in almost all of the metaphases. Furthermore, we observed micronuclei, which were equivalent to the rDNA of the 15p+hsr demonstrated by FISH in the same preparation. In contrast, the DNA cross-linking agent mitomycin C (MMC) preferentially induced 15p+hsr-negative micronuclei. These findings indicated that chromatin decondensation and subsequent DNA strand breakage induced by the demethylating effect of 5-azaC led specifically to 15p+hsr-positive micronuclei.


Assuntos
Azacitidina/farmacologia , Cromatina/efeitos dos fármacos , Cromossomos Humanos Par 15/efeitos dos fármacos , Azacitidina/toxicidade , Células Cultivadas/efeitos dos fármacos , Células Cultivadas/ultraestrutura , Cromatina/ultraestrutura , Quebra Cromossômica , Cromossomos Humanos Par 15/genética , Cromossomos Humanos Par 15/ultraestrutura , Reagentes de Ligações Cruzadas/farmacologia , Reagentes de Ligações Cruzadas/toxicidade , Dano ao DNA , Metilação de DNA/efeitos dos fármacos , DNA Ribossômico/efeitos dos fármacos , DNA Satélite/efeitos dos fármacos , DNA Satélite/ultraestrutura , Fibroblastos/efeitos dos fármacos , Fibroblastos/ultraestrutura , Heterocromatina/efeitos dos fármacos , Heterocromatina/ultraestrutura , Humanos , Hibridização in Situ Fluorescente , Pulmão/citologia , Masculino , Testes para Micronúcleos , Mitomicina/farmacologia , Mitomicina/toxicidade
19.
DNA Repair (Amst) ; 2(9): 983-90, 2003 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-12967655

RESUMO

Barley nucleolus organizing regions (NORs) were previously found to behave as prominent aberration hot-spots after treatment with some restriction endonucleases. The ability of MspI for directed induction of double-strand breaks in barley ribosomal DNA was further analyzed. Ionizing radiation-produced strand breakage within the ribosomal gene clusters was also a subject of investigation. Reconstructed barley karyotypes T1586 and T35 with normal and increased expression of rRNA genes were utilized to evaluate the relationship between transcriptional activity and damage induction. Scanning densitometry of the hybridization profiles revealed that MspI is generating double-strand breaks in barley rDNA with efficiency being independent from the NOR activity. Damage induction observed after treatment with gamma-rays was also not influenced by the transcriptional status of the ribosomal genes. A tendency towards restoration of rDNA integrity after irradiation of both germinating and dry seeds was observed which is indicative for the efficient recovery of double-strand breaks in barley ribosomal DNA.


Assuntos
Dano ao DNA , Reparo do DNA , DNA Ribossômico/genética , Hordeum/genética , DNA de Plantas/efeitos dos fármacos , DNA de Plantas/genética , DNA de Plantas/efeitos da radiação , DNA Ribossômico/efeitos dos fármacos , DNA Ribossômico/efeitos da radiação , Desoxirribonuclease HpaII/toxicidade , Relação Dose-Resposta à Radiação , Hordeum/efeitos dos fármacos , Cariotipagem
20.
EMBO J ; 21(18): 4959-68, 2002 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-12234935

RESUMO

rRNA transcription in Saccharomyces cerevisiae is performed by RNA polymerase I and regulated by changes in growth conditions. During log phase, approximately 50% of the ribosomal DNA (rDNA) genes in each cell are transcribed and maintained in an open, psoralen-accessible conformation. During stationary phase, the percentage of open rDNA genes is greatly reduced. In this study we found that the Rpd3 histone deacetylase was required to inactivate (close) individual rDNA genes as cells entered stationary phase. Even though approximately 50% of the rDNA genes remained open during stationary phase in rpd3Delta mutants, overall rRNA synthesis was still reduced. Using electron microscopy of Miller chromatin spreads, we found that the number of RNA polymerases transcribing each open gene in the rpd3Delta mutant was significantly reduced when cells grew past log phase. Bulk levels of histone H3 and H4 acetylation were reduced during stationary phase in an RPD3-dependent manner. However, histone H3 and H4 acetylation was not significantly altered at the rDNA locus in an rpd3Delta mutant. Rpd3 therefore regulates the number of open rDNA repeats.


Assuntos
DNA Ribossômico/genética , Genes Fúngicos , Histona Desacetilases/metabolismo , Proteínas Repressoras , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/genética , Fatores de Transcrição , Transcrição Gênica , Acetilação , Cromatina/metabolismo , Cromatina/ultraestrutura , Reagentes de Ligações Cruzadas/farmacologia , DNA Fúngico/genética , DNA Fúngico/metabolismo , DNA Ribossômico/efeitos dos fármacos , Ficusina/farmacologia , Histonas/metabolismo , Mutação , RNA Polimerase I/metabolismo , Saccharomyces cerevisiae/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...